ArticlePloS one2013

High-purity preparation of HSV-2 vaccine candidate ACAM529 is immunogenic and efficacious in vivo.

Sophia T Mundle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.